Colon cancer is now the deadliest cancer for people under 50, and researchers are scrambling to understand why rectal cases ...
FENhance 1 met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses by 51% compared to teriflunomide in relapsing multiple sclerosis (RMS), consistent with ...
Colorectal cancer is now the leading cause of cancer deaths in people younger than 50. While routine screening is recommended ...